What caused the SKIN.SW stock jump today?

Intraday volume rose to 2,756 shares and buyers pushed price to CHF35.70. The move was likely driven by short-term trading, sector interest in healthcare, and positioning ahead of biotech catalysts

Is SKIN.SW stock a buy after the intraday rise?

Meyka AI rates SKIN.SW B (HOLD). We advise cautious trading. Consider liquidity, negative EPS and upcoming clinical milestones before increasing exposure

What are key support and resistance levels for SKIN.SW stock?

Near-term support is around the session low and open at CHF32.00. Immediate resistance is CHF36.00 and the 200-day average at CHF37.22. Use these levels for trade management

What price target does Meyka AI have for SKIN.SW stock?

Meyka AI's forecast model projects a 12-month target of CHF42.00, implying a 17.65% upside from the current CHF35.70. Forecasts are model-based and not guarantees

CH Stocks

SKIN.SW up 9.85% intraday on SIX 03 Mar 2026: Volume spike tests trend

ByDanny Kontos March 3, 2026

SKIN.SW stock jumped 9.85% intraday to CHF35.70 on SIX on 03 Mar 2026, led by a volume surge to 2,756 shares versus a 50-day average of 1,818. The move pushed the intraday high to CHF36.00 from an open at CHF32.00, signalling traders are active in Cassiopea S.p.A. (SKIN.SW) during today’s session. We track how volume, technical levels and biotech catalysts are shaping the trade for SKIN.SW stock and what that means for near-term liquidity and price support